Subsequent investigations (42) as reported by Cancer Cell International, found that patients with advanced stages of cervical cancer (stages III and IV) exhibited significantly higher expression of FTO than those in the early stages (stages I and II) or those with a normal cervix. The gene discussed is FTO; the disease is cervical carcinoma.